CogniAble Competitors

Maven Clinic is the world's largest virtual clinic for women and families on a mission to make healthcare work for all of us. Through Maven Enterprise, the company partners with more than 2,300 employers and health plans to provide end-to-end women's and family health programs spanning fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause and midlife — improving clinical outcomes, reducing healthcare costs, and expanding equitable access to high-quality care at scale. Through its consumer platform, Maven provides direct access to virtual care across 30+ specialties, as well as dedicated hormone and GLP-1 care programs purpose-built for women. Founded in 2014 by CEO Kate Ryder, Maven Clinic has raised more than $425 million from leading healthcare and technology investors including General Catalyst, Sequoia, Dragoneer Investment Group, Oak HC/FT, StepStone Group, Icon Ventures, and Lux Capital. Recognized for innovation and industry leadership, Maven has been named to the TIME100 Most Influential Companies, CNBC Disruptor 50, Fast Company's Most Innovative Companies, and FORTUNE Best Places to Work. Learn more at mavenclinic.com

CognitiveScale pioneered the concept of ‘Trusted AI”, paving the way for responsible Enterprise AI development worldwide. Backed by 164 AI patents, the Cortex platform empowers data scientists and citizen developers to build, understand and analyze intelligent, transparent & trusted AI systems using any data, on any cloud. By simplifying the development, deployment and management of AI systems, CognitiveScale is revolutionizing how organizations across industries–healthcare, financial services, insurance and digital commerce– engage with customers, optimize services and deliver on bottom line goals—all while protecting them from business risk. Headquartered in Austin, Texas, CognitiveScale is recognized by the World Economic Forum for positively impacting business and society through AI with active investment from Norwest Venture Partners, Intel Capital, IBM Watson, M12 (Microsoft Ventures), and USAA.

NeuroLeap’s solution uses multi-sensory & dynamic feedback technologies that incorporate children’s innate desire to play. Schools can now much better meet their legal requirement to educate children with learning disabilities, in a cost effective way.